|
?:authorAffiliation
|
-
[\'Department of Global Health,International Clinical Research Center (ICRC), University of Washington, UW Box 359927, 325 Ninth Avenue, Seattle, WA, 98104, USA. rbarnaba@uw.edu.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Department of Epidemiolog, University of Washington, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. rbarnaba@uw.edu.\', \'Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Biostatistics, University of Washington, Seattle, WA, USA.\', \'New York University School of Medicine, New York, NY, USA.\', \'Bill and Melinda Gates Foundation, Seattle, WA, USA.\', \'Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.\', \'Department of Global Health,International Clinical Research Center (ICRC), University of Washington, UW Box 359927, 325 Ninth Avenue, Seattle, WA, 98104, USA.\', \'Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.\', \'Department of Epidemiolog, University of Washington, Seattle, WA, USA.\', \'Certara, Princeton, NJ, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}